// App-Quantinova.ai

TCT-181 : Outcomes of Left Main PCI vs CABG According the Number of Diseased Coronary Arteries: The EXCEL trial

Researchers

Presenter

  • Erick Schampaert

Principal Investigators

  • Patrick Serruys

  • A. Pieter Kappetein

  • Nicholas Lembo

  • William Brown

  • Adrian Banning

  • Ovidiu Dressler

  • Serge Doucet

  • Uday Trivedi

  • David Hildick-Smith

  • Joseph Sabik

  • Gregg Stone

Medical Centers

  • Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Piedmont Heart Institute CardioThoracic Surgeons, Atlanta, Georgia, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Imperial College, London, United Kingdom

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • Cardiovascular Research Foundation, New York, New York, United States

  • Columbia University, New York, New York, United States

  • John Radcliffe Hospital, Oxford, United Kingdom.

  • MHI, Montreal, Quebec, Canada

Locations

  • Canada

  • United States

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved